Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A Novel Ultrasound Phased Array and Sonication Method for Stroke Treatments

Award Number: R01EB009032
ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/30/2008
PERIOD OF PERFORMANCE END DATE: 08/31/2015

Group Awards By:

View Award Description

A Novel Ultrasound Phased Array and Sonication Method for Stroke Treatments - DESCRIPTION (provided by applicant): In order to exploit the potential of focused ultrasound therapy, high-power phased array transducers with large number of elements are required. Current methods have two major drawbacks. First, the electrical impedance of individual array elements becomes large as their size is reduced. Second, arrays are not able to deliver adequate acoustic power for some advanced applications. We have discovered a method to overcome both of these limitations and propose to develop new phased array technology for therapeutic ultrasound based on this approach. More specifically in this proposal we will develop a system based on this technology for the treatment of stroke. Despite millions of dollars spent on acute stroke intervention trials over the last decade, only strategies that open blocked arteries and reperfuse ischemic penumbra within 3-6 hours of onset have proven to be effective. Clinical studies have shown that transcranial ultrasound and Doppler ultrasound can significantly increase the number of patients that will have recanalization of the occluded vessel when administrated together with tissue plasminogen activator (tPA). However, there are still a large number of patients whose arterial occlusion is not resolved with the current use of Doppler ultrasound exposure. It is our hypothesis that transcranial sonication using phased array applicators and patient-specific skull information derived from CT scans can better localize ultrasound energy within the brain, and that this will result in further improvements in patient response as compared with existing approaches. Precise localization of ultrasound energy within the brain could also enable the use of ultrasound alone without a thrombolytic agent thus eliminating the potential side effects of these substances. The specific tasks to be completed during this grant period are: First, development of the new array technology, second, development of an ultrasound system for the treatment of stroke, third, measurements of skull properties at the required frequency range, and fourth, tests of the complete system with ex vivo human skulls. In addition we will determine the optimal ultrasound exposures for the stroke treatments with and without tPA using ex vivo and in vivo models. Finally, we will test the short and long term impact of the treatments in two different animal models. At the end of this research we will have developed a phased array technology that can overcome the remaining barriers in applying this technology optimally for ultrasound therapy. In addition we will have completed a prototype system and will have conducted pre-requisite preclinical testing to be in a position for subsequent clinical trials for the treatment of acute stroke. Public Health Relevance Statement (provided by applicant): Despite millions of dollars spent on acute stroke intervention trials over the last decade, only strategies that open blocked arteries and reperfuse ischemic penumbra within 3-6 hours of onset have proven to be effective. Only a few percent of all stroke patients receive clot-busting treatments, however, due to the system requirements to deliver appropriate care. It is our hypothesis that a larger number of patients could benefit from these treatments if advanced phased array systems are used to accelerate thrombolysis. The phased arrays would allow predictable ultrasound exposures and minimize impact on the surrounding tissues. During this research we plan to develop such a system and perform all of the experiments needed prior to starting clinical trials. This research may have a major impact on patient care.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2014 ( Subtotal = $0 )
2014	2012	SUNNYBROOK HEALTH SCIENCES CENTRE	2075 BAYVIEW AVENUE	TORONTO		00000		CAN	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	5	8/25/2014	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2012 ( Subtotal = $392,066 )
2012	2012	SUNNYBROOK HEALTH SCIENCES CENTRE	2075 Bayview Avenue	TORONTO				CAN	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	5	8/15/2012	NON-COMPETING CONTINUATION	$392,066
														Subtotal = $392,066

Issue Date FY: 2011 ( Subtotal = $410,881 )
2011	2011	SUNNYBROOK HEALTH SCIENCES CENTRE	2075 Bayview Avenue	TORONTO				CAN	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	4	8/15/2011	NON-COMPETING CONTINUATION	$410,881
														Subtotal = $410,881

Issue Date FY: 2010 ( Subtotal = $421,835 )
2010	2010	SUNNYBROOK & WOMENS COLL HLTH SCIS CTR	2075 Bayview Avenue	TORONTO				CAN	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	3	8/6/2010	NON-COMPETING CONTINUATION	$421,835
														Subtotal = $421,835

Issue Date FY: 2009 ( Subtotal = $413,689 )
2009	2009	SUNNYBROOK & WOMENS COLL HLTH SCIS CTR	2075 Bayview Avenue	TORONTO				CAN	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	2	8/25/2009	NON-COMPETING CONTINUATION	$413,689
														Subtotal = $413,689

Grand Total All Awards = $1,638,471

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Novel Ultrasound Phased Array and Sonication Method for Stroke Treatments

Award Number: R01EB009032

ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/30/2008

PERIOD OF PERFORMANCE END DATE: 08/31/2015

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer